X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
index medicus (57) 57
genotype (36) 36
male (35) 35
female (34) 34
hepacivirus - genetics (33) 33
hepatitis (30) 30
antiviral agents - therapeutic use (28) 28
adult (27) 27
middle aged (25) 25
mutation (25) 25
virology (25) 25
hepatitis c virus (24) 24
hepatitis c (22) 22
genotype & phenotype (21) 21
ribavirin (21) 21
gastroenterology & hepatology (20) 20
hepatitis c, chronic - drug therapy (20) 20
sofosbuvir (20) 20
aged (19) 19
drug therapy, combination (19) 19
infectious diseases (19) 19
microbiology (19) 19
treatment outcome (19) 19
abridged index medicus (18) 18
replication (17) 17
hepatitis c - drug therapy (16) 16
uridine monophosphate - analogs & derivatives (16) 16
drug resistance, viral - genetics (15) 15
patients (15) 15
therapy (15) 15
viruses (15) 15
uridine monophosphate - therapeutic use (14) 14
antiviral agents - administration & dosage (13) 13
antiviral agents - adverse effects (13) 13
cell line (13) 13
cirrhosis (13) 13
drug resistance, viral (13) 13
drug therapy (13) 13
gastroenterology and hepatology (13) 13
genotypes (13) 13
hepatitis c, chronic - virology (13) 13
resistance (13) 13
ribavirin - therapeutic use (13) 13
antiviral agents (12) 12
drug resistance (12) 12
hcv (12) 12
hepacivirus - drug effects (12) 12
hiv-1 - genetics (12) 12
infections (12) 12
chemistry (11) 11
health aspects (11) 11
hepatitis c - virology (11) 11
hepatitis-c virus (11) 11
hiv infections - drug therapy (11) 11
hiv-1 - drug effects (11) 11
immunology (11) 11
metallurgy (11) 11
organic chemistry (11) 11
pharmacology & pharmacy (11) 11
sustained virologic response (11) 11
viral load (11) 11
viral nonstructural proteins - genetics (11) 11
benzimidazoles - therapeutic use (10) 10
care and treatment (10) 10
clinical trials (10) 10
direct-acting antivirals (10) 10
dna (10) 10
fluorenes - therapeutic use (10) 10
genetic aspects (10) 10
infection (10) 10
interferon (10) 10
sofosbuvir - therapeutic use (10) 10
treatment-naive patients (10) 10
antiretroviral drugs (9) 9
human immunodeficiency virus--hiv (9) 9
human-immunodeficiency-virus (9) 9
sofosbuvir - administration & dosage (9) 9
variants (9) 9
viral nonstructural proteins - antagonists & inhibitors (9) 9
analysis (8) 8
animals (8) 8
combination (8) 8
high-throughput nucleotide sequencing (8) 8
medicine, general & internal (8) 8
molecular sequence data (8) 8
phase-2 trial (8) 8
ribavirin - adverse effects (8) 8
tenofovir (8) 8
uridine monophosphate - adverse effects (8) 8
acyclic or carbocyclic compounds (7) 7
adenine - analogs & derivatives (7) 7
amino acid substitution (7) 7
antiviral activity (7) 7
benzimidazoles - administration & dosage (7) 7
efficacy (7) 7
fluorenes - administration & dosage (7) 7
genotype 1 (7) 7
heterocyclic compounds (7) 7
hiv infections - virology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9973, pp. 1098 - 1106
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 1, pp. 34 - 44
In this small, preliminary study of sofosbuvir, a nucleotide inhibitor of HCV polymerase, treatment with sofosbuvir and ribavirin, without peginterferon, was... 
GENOTYPE 1 | PSI-7977 | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | THERAPY | REPLICATION | RESISTANCE | REPLICON RNA-SYNTHESIS | COMBINATION | TREATMENT-NAIVE PATIENTS | PROTEASE | Recombinant Proteins - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Viral Load | Adult | Female | RNA, Viral - metabolism | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - isolation & purification | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Hemoglobins - metabolism | Genotype | Hepatitis C, Chronic - drug therapy | Hepatitis C, Chronic - blood | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Interferon-alpha - adverse effects | Viral Nonstructural Proteins - antagonists & inhibitors | Sofosbuvir | Drugs | Dose-response relationship (Biochemistry) | Antiviral agents | Usage | Patient outcomes | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Hepatitis | Interferon | Infections | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1993 - 2001
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2599 - 2607
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1879 - 1888
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2134 - 2146
Journal Article
Hepatology, ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 371 - 378
Journal Article